- Home
- SGHT vs OPP Comparison
SGHT vs OPP Comparison
Compare SGHT & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- OPP
- Stock Information
- Founded
- SGHT 2011
- OPP 2010
- Country
- SGHT United States
- OPP United States
- Employees
- SGHT N/A
- OPP N/A
- Industry
- SGHT Medical Specialities
- OPP Finance/Investors Services
- Sector
- SGHT Health Care
- OPP Finance
- Exchange
- SGHT Nasdaq
- OPP Nasdaq
- Market Cap
- SGHT 193.2M
- OPP 208.6M
- IPO Year
- SGHT 2021
- OPP N/A
- Fundamental
- Price
- SGHT $3.49
- OPP $8.64
- Analyst Decision
- SGHT Buy
- OPP
- Analyst Count
- SGHT 8
- OPP 0
- Target Price
- SGHT $4.29
- OPP N/A
- AVG Volume (30 Days)
- SGHT 108.2K
- OPP 108.0K
- Earning Date
- SGHT 11-06-2025
- OPP 01-01-0001
- Dividend Yield
- SGHT N/A
- OPP 14.41%
- EPS Growth
- SGHT N/A
- OPP N/A
- EPS
- SGHT N/A
- OPP N/A
- Revenue
- SGHT $76,303,000.00
- OPP N/A
- Revenue This Year
- SGHT N/A
- OPP N/A
- Revenue Next Year
- SGHT $12.04
- OPP N/A
- P/E Ratio
- SGHT N/A
- OPP N/A
- Revenue Growth
- SGHT N/A
- OPP N/A
- 52 Week Low
- SGHT $2.03
- OPP $7.26
- 52 Week High
- SGHT $7.03
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- SGHT 49.70
- OPP 45.34
- Support Level
- SGHT N/A
- OPP $8.70
- Resistance Level
- SGHT $3.65
- OPP $8.78
- Average True Range (ATR)
- SGHT 0.16
- OPP 0.07
- MACD
- SGHT -0.19
- OPP -0.01
- Stochastic Oscillator
- SGHT 82.12
- OPP 29.38
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.